These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
430 related articles for article (PubMed ID: 25791321)
21. [Sclerosing encapsulating peritonitis in a patient treated with atenolol being]. Santos-Magadán S; Chiva-de-Agustín M Radiologia; 2014; 56(6):561-2. PubMed ID: 23623307 [No Abstract] [Full Text] [Related]
22. Atypical pityriasis rosea or psoriasis guttata? Early examination is the key to a correct diagnosis. Eslick GD Int J Dermatol; 2002 Nov; 41(11):788-91. PubMed ID: 12453007 [TBL] [Abstract][Full Text] [Related]
23. Pityriasis rosea-like eruption due to pneumococcal vaccine in a child with nephrotic syndrome. Sasmaz S; Karabiber H; Boran C; Garipardic M; Balat A J Dermatol; 2003 Mar; 30(3):245-7. PubMed ID: 12692364 [TBL] [Abstract][Full Text] [Related]
24. Pityriasis rosea-like eruption in a patient receiving omeprazole. Buckley C Br J Dermatol; 1996 Oct; 135(4):660-1. PubMed ID: 8915176 [No Abstract] [Full Text] [Related]
25. Manifestation of pityriasis rosea and pityriasis rosea-like eruptions after Covid-19 vaccine: A systematic review. Khan I; Elsanousi AA; Shareef AM; Tebha SS; Arif A; Gul S Immun Inflamm Dis; 2023 Apr; 11(4):e804. PubMed ID: 37102660 [TBL] [Abstract][Full Text] [Related]
31. Tongue and cheek: oral lesions in pityriasis rosea. Vidimos AT; Camisa C Cutis; 1992 Oct; 50(4):276-80. PubMed ID: 1424793 [TBL] [Abstract][Full Text] [Related]
32. Identifying iatrogenic depression using confirmatory factor analysis of the Center for Epidemiologic Studies Depression Scale in patients prescribed a verapamil-sustained-release-led or atenolol-led hypertension treatment strategy. Wilson DL; Ried LD Res Social Adm Pharm; 2012; 8(4):309-20. PubMed ID: 22133650 [TBL] [Abstract][Full Text] [Related]
33. A clinicoepidemiological study of pityriasis rosea in South India. Ganguly S Skinmed; 2013; 11(3):141-6. PubMed ID: 23930352 [TBL] [Abstract][Full Text] [Related]
34. Coexistence of two atypical variants of pityriasis rosea: a case report and review of literature. Sinha S; Sardana K; Garg VK Pediatr Dermatol; 2012; 29(4):538-40. PubMed ID: 21906158 [TBL] [Abstract][Full Text] [Related]
35. The significance of investigating clinical, histopathologic and virological features in pityriasis rosea and pityriasis rosea-like eruptions following COVID-19 vaccinations. Ciccarese G; Parodi A; Drago F Dermatol Ther; 2022 Aug; 35(8):e15601. PubMed ID: 35622411 [No Abstract] [Full Text] [Related]
36. Pityriasis rosea is associated with systemic active infection with both human herpesvirus-7 and human herpesvirus-6. Watanabe T; Kawamura T; Jacob SE; Aquilino EA; Orenstein JM; Black JB; Blauvelt A J Invest Dermatol; 2002 Oct; 119(4):793-7. PubMed ID: 12406322 [TBL] [Abstract][Full Text] [Related]
37. Terbinafine induced pityriasis rosea-like eruption. George A; Bhatia A; Kanish B; Williams A Indian J Pharmacol; 2015; 47(6):680-1. PubMed ID: 26729964 [TBL] [Abstract][Full Text] [Related]
38. Pityriasis rosea in a patient with Behçet's disease treated with interferon alpha 2A. Durusoy C; Alpsoy E; Yilmaz E J Dermatol; 1999 Apr; 26(4):225-8. PubMed ID: 10343467 [TBL] [Abstract][Full Text] [Related]
39. Palmar herald patch in pityriasis rosea. Polat M; Yildirim Y; Makara A Australas J Dermatol; 2012 Aug; 53(3):e64-5. PubMed ID: 22881477 [TBL] [Abstract][Full Text] [Related]